锥形直柄无领喷砂钛合金股骨柄平均随访24年的长期生存率与结果
本研究对119例患者147个CLS Spotorno股骨柄进行平均24年(20-30年)的生存分析,30年总体估计生存率为89.9%(95%CI 83.5-93.9),以无菌性松动翻修为终点的生存率为93.1%(95%CI 87.1-96.4)。结论认为该无骨水泥股骨柄24年结果满意且30年估计生存率高,但手术时年龄低于50岁的患者股骨柄翻修风险增加。
要点
- CLS Spotorno股骨柄30年总体估计生存率为89.9%(95%CI 83.5-93.9)。
- 以无菌性松动翻修为终点的30年生存率为93.1%(95%CI 87.1-96.4)。
- 手术时年龄大于50岁患者生存率更好(P = .026),低于50岁翻修风险增加。
核心结论
- 无骨水泥CLS Spotorno股骨柄植入后24年结果满意,至术后30年估计生存率高。
- 手术时年龄低于50岁的患者股骨柄翻修风险增加。
研究设计与样本
- 对119例患者147个CLS Spotorno股骨柄进行生存分析,平均随访24年(20-30年)。
- 随访期间33例患者(39髋)死亡,其死亡时假体生存信息从亲属和全科医生处获取。
- 66例患者(86髋)完成完整调查及影像学检查,18例受试者(20髋)接受电话访谈。
- 评估影响生存的因素、功能结局和手术满意度。
主要发现
- 股骨柄30年总体估计生存率为89.9%(95%CI 83.5-93.9)。
- 以无菌性松动行股骨翻修为终点的生存率为93.1%(95%CI 87.1-96.4)。
- 最差情况下,24年时总体假体生存率为77.2%(95%CI 80.3-82.7,原文如此)。
- 手术时年龄大于50岁患者生存率更好(P = .026)。
- 随访时平均Harris髋关节评分为83.1(范围43-100),满意度为9/10;术后满意度主要决定因素为Harris髋关节评分,影像学改变对结局变异解释很少。
关键数值与推荐
- 30年总体估计生存率89.9%(95%CI 83.5-93.9)。
- 以无菌性松动翻修为终点的30年生存率93.1%(95%CI 87.1-96.4)。
- 最差情况下24年总体假体生存率77.2%(95%CI 80.3-82.7,原文如此)。
- 手术时年龄大于50岁患者生存率更好(P = .026)。
- 随访时平均Harris髋关节评分83.1(范围43-100),满意度9/10。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is limited evidence on the survivorship of patients who undergo cementless stem implantation, beyond 20 years of the hip arthroplasty. We report implant survival and results of the CLS Spotorno femoral stem until 30 years from implantation. METHODS: Survival analysis of 147 CLS Spotorno stems in 119 patients for an average period of 24 years (20-30) from the date of implantation was performed. During the course of the follow-up period, 33 patients (39 hips) died. The information on the survival of their hip implant at the time of death was gathered from their relatives and general practitioners. Sixty-six patients (86 hips) undertook the complete survey along with radiographic examination, while 18 subjects (20 hips) were interviewed over the telephone. The factors influencing survival, functional outcomes, and level of satisfaction with surgery were evaluated. RESULTS: The overall estimated survival of the stems was 89.9% after 30 years (95% confidence interval [CI] 83.5-93.9). Survival with femoral revision for aseptic loosening as an end point was 93.1% (95% CI 87.1-96.4). In the worst-case scenario, an overall implant survival of 77.2% (95 CI% 80.3-82.7) was observed after 24 years. Patients who were older than 50 in age at the time of surgery had better survival rates (P = .026). The mean Harris Hip Score at follow-up was 83.1 (range 43-100) and the level of satisfaction was 9/10. The main determinant of postsurgical satisfaction was Harris Hip Score, whereas radiographic alterations explained little with respect to the variation in the outcomes. CONCLUSION: The cementless CLS Spotorno stem displayed satisfactory results 24 years after implantation and high estimated survival until 30 years from surgery. However, patients below the age of 50 at the time of surgery have an increased risk of undergoing revision of their femoral stem.
引用
- Rizzo M, Balato G, Cerbasi S, et al. Long-Term Survival and Results at a Mean Follow-Up Period of 24 Years of a Tapered Straight, Collarless, Grit-Blasted, Titanium Alloy Stem. J Arthroplasty. 2020. PMID: 32660799. doi:10.1016/j.arth.2020.06.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。